Clinical Trial

4D-710 in Adult Patients With Cystic Fibrosis

Name: 4D-710 in Adult Patients With Cystic Fibrosis — clinical trial record (NCT05248230)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CF

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis.

Protocol Amendment History 19 amendments

This ClinicalTrials.gov record has been amended 19 times since 2022-02-10; most recent amendment 2026-07-01.

Trial Details

NCT Number	NCT05248230
Lead Sponsor	4D Molecular Therapeutics
Conditions	Cystic Fibrosis Lung
Enrollment	30 participants
Start Date	2022-03-29
Primary Completion	2027-06 (estimated)
Study Completion	2031-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-06